A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy, Safety and Tolerability of Orally Administered BI 409306 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 329
- 试验地点
- 60
- 主要终点
- Change From Baseline in Neuropsychological Test Battery in Total Z-score After 12-week Treatment.
研究概览
简要总结
The study is designed to compare the effects of BI 409306 compared to placebo in patients with cognitive impairment due to Alzheimer's Disease
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 55 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
BI 409306 dose 4
干预措施: Placebo (Drug)
BI 409306 dose 4
干预措施: BI 409306 (Drug)
Placebo comparator
干预措施: Placebo (Drug)
BI 409306 dose 1
干预措施: Placebo (Drug)
BI 409306 dose 1
干预措施: BI 409306 (Drug)
BI 409306 dose 2
干预措施: Placebo (Drug)
BI 409306 dose 2
干预措施: BI 409306 (Drug)
BI 409306 dose 3
干预措施: Placebo (Drug)
BI 409306 dose 3
干预措施: BI 409306 (Drug)
Active Comparator Donepezil
干预措施: Placebo (Drug)
Active Comparator Donepezil
干预措施: Donepezil (Drug)
结局指标
主要结局
Change From Baseline in Neuropsychological Test Battery in Total Z-score After 12-week Treatment.
时间窗: Baseline and 12 weeks
Neuropsychological Test Battery (NTB) response, defined as change from baseline in total z-score after 12 weeks of treatment. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Negative numbers indicate values lower than baseline and positive numbers indicate values higher than baseline. Least Squares Mean is actually an adjusted mean change from baseline.
Change From Baseline in Neuropsychological Test Battery in Total Z-score After 12-week Treatment From Two Sister Trials, Present 1289.5 (NCT02240693) and 1289.7 (NCT02337907)
时间窗: Baseline and 12 weeks
Neuropsychological Test Battery (NTB) response, defined as change from baseline in total z-score after 12 weeks of treatment. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Negative numbers indicate values lower than baseline and positive numbers indicate values higher than baseline. The number of low test scores decreased with higher levels of intellectual abilities. Least Squares Mean is actually an adjusted mean change from baseline.
次要结局
- Change From Baseline in Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Total Score After 12-week Treatment(Baseline and 12 weeks)
- Change From Baseline in Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) Total Score After 12-week Treatment(Baseline and 12 weeks)
- Change From Baseline in Alzheimer's Disease Assessment Scale-cognitive Subscale (ADAS-cog11) Total Score After 12-week Treatment(Baseline and 12 weeks)
